Arbutus Biopharma
ABUS
#6408
Rank
โ‚ฌ0.58 B
Marketcap
3,07ย โ‚ฌ
Share price
0.00%
Change (1 day)
42.99%
Change (1 year)

Revenue for Arbutus Biopharma (ABUS)

Revenue in 2024 (TTM): โ‚ฌ6.16 Million

According to Arbutus Biopharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ6.45 Million. In 2023 the company made a revenue of โ‚ฌ16.41 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ36.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arbutus Biopharma from 2008 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ6.16 M-62.42%
2023 โ‚ฌ16.41 M-54.89%
2022 โ‚ฌ36.37 M274.91%
2021 โ‚ฌ9.7 M72.6%
2020 โ‚ฌ5.62 M4.76%
2019 โ‚ฌ5.36 M3.26%
2018 โ‚ฌ5.19 M-41.73%
2017 โ‚ฌ8.91 M529.12%
2016 โ‚ฌ1.41 M-93.77%
2015 โ‚ฌ22.74 M85.02%
2014 โ‚ฌ12.29 M9.7%
2013 โ‚ฌ11.2 M5.79%
2012 โ‚ฌ10.59 M-18.55%
2011 โ‚ฌ13 M-18.9%
2010 โ‚ฌ16.03 M75.6%
2009 โ‚ฌ9.13 M30.47%
2008 โ‚ฌ7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.13 B 2,038.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas